Sumitomo Seika Chemicals Company, Limited.

TSE:4008 Voorraadrapport

Marktkapitalisatie: JP¥66.9b

Sumitomo Seika Chemicals Company Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Sumitomo Seika Chemicals Company has been growing earnings at an average annual rate of 21%, while the Chemicals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 9.2% per year. Sumitomo Seika Chemicals Company's return on equity is 8.1%, and it has net margins of 5.5%.

Belangrijke informatie

21.0%

Groei van de winst

21.5%

Groei van de winst per aandeel

Chemicals Groei van de industrie6.6%
Inkomstengroei9.2%
Rendement op eigen vermogen8.1%
Nettomarge5.5%
Volgende winstupdate11 Nov 2024

Recente prestatie-updates uit het verleden

There May Be Some Bright Spots In Sumitomo Seika Chemicals Company's (TSE:4008) Earnings

May 21
There May Be Some Bright Spots In Sumitomo Seika Chemicals Company's (TSE:4008) Earnings

Recent updates

Sumitomo Seika Chemicals Company, Limited.'s (TSE:4008) Shares Lagging The Market But So Is The Business

Aug 06
Sumitomo Seika Chemicals Company, Limited.'s (TSE:4008) Shares Lagging The Market But So Is The Business

There May Be Some Bright Spots In Sumitomo Seika Chemicals Company's (TSE:4008) Earnings

May 21
There May Be Some Bright Spots In Sumitomo Seika Chemicals Company's (TSE:4008) Earnings

Opbrengsten en kosten

Hoe Sumitomo Seika Chemicals Company geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

TSE:4008 Opbrengsten, kosten en inkomsten (JPY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24145,7827,96016,1252,662
31 Mar 24142,9866,16615,7662,711
31 Dec 23141,4884,68515,5312,703
30 Sep 23139,2625,53515,6422,769
30 Jun 23140,1946,82316,2582,750
31 Mar 23143,0418,59217,0102,670
31 Dec 22140,1459,10417,5492,711
30 Sep 22138,8269,08617,6052,534
30 Jun 22126,5706,59716,8432,580
31 Mar 22115,5835,89515,4862,590
31 Dec 21112,2246,23414,2452,617
30 Sep 21102,5776,20813,0942,754
30 Jun 21101,5176,56412,3392,834
31 Mar 21103,2547,11912,1932,881
31 Dec 20100,2276,55511,8172,964
30 Sep 20101,9356,26611,7393,051
30 Jun 20102,7775,66911,6463,079
31 Mar 2099,7014,28511,4323,177
31 Dec 19100,852-83111,5683,216
30 Sep 19103,323-88011,9143,125
30 Jun 19107,045-29912,2743,005
31 Mar 19109,63460412,4732,896
31 Dec 18111,3185,98212,7122,833
30 Sep 18109,9596,34412,5772,758
30 Jun 18108,1446,89112,4592,751
31 Mar 18105,8836,69812,4122,715
31 Dec 17104,7056,46412,0372,486
30 Sep 17102,2716,85811,9282,483
30 Jun 1798,5566,33711,7482,440
31 Mar 1798,8575,73911,7272,383
31 Dec 1692,9544,86711,5832,439
30 Sep 1692,0174,28811,5012,370
30 Jun 1691,1694,03611,4122,321
31 Mar 1687,0034,01311,2762,284
31 Dec 1589,1664,52411,4332,350
30 Sep 1587,8604,88011,2962,267
30 Jun 1591,4385,72911,1482,286
31 Mar 1592,6985,54311,1912,251
31 Dec 1494,3225,67510,9621,961
30 Sep 1494,7885,31710,9412,052
30 Jun 1491,5434,90710,7641,985
31 Mar 1494,9115,65610,8382,087
31 Dec 1391,5896,30610,5362,170

Kwaliteitswinsten: 4008 has high quality earnings.

Groeiende winstmarge: 4008's current net profit margins (5.5%) are higher than last year (4.9%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 4008 has become profitable over the past 5 years, growing earnings by 21% per year.

Versnelling van de groei: 4008's earnings growth over the past year (16.7%) is below its 5-year average (21% per year).

Winst versus industrie: 4008 earnings growth over the past year (16.7%) exceeded the Chemicals industry 12.3%.

Rendement op eigen vermogen

Hoge ROE: 4008's Return on Equity (8.1%) is considered low.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y